Facebook blocks Road 96 ads as they deal with politics, disbelieving developers

Facebook blocks Road 96 ads as they deal with politics, disbelieving developers

Facebook blocks Road 96 ads as they deal with politics

Facebook has blocked ads for the adventure game Road 96 claiming that the content shown is not appropriate for the platform, as it displays social, electoral or political messages. Speaking to Axios, Road 96 developer Yoan Fanise expressed disbelief.

Fanise initially thought this was a joke. Recall that Road 96 is a procedural adventure game that sees us in the role of a character who must escape from a problematic nation and try to reach the border: advertising includes these elements and, probably, Facebook automatically decided that this content was too political.

Road 96 However, the developer explained that Road 96 is not just about these issues. There is also talk of hitchhiking, meeting new people and much more. It is a person's journey to freedom. Fanise had the possibility to change the advertisement or obtain an authorization to carry out a political advertisement: the developer however preferred to put the question aside and not publish any advertisements on Facebook.

He also expressed his own doubts about Facebook's method of control, even making a comparison with Minority Report (a dystopian work in which crimes are blocked before they are even committed). Facebook has not provided statements on the Road 96 case and has not explained its methods of control.

If you are interested in Road 96, here is the proof of this promising procedural venture.

Source Did you notice errors?

Vaccine inequity: Inside the cutthroat race to secure doses

Although the World Bank and the International Monetary Fund had between them set aside billions for vaccinating the developing world, that money was intended to go to countries and was out of bounds for a global vaccine sharing plan like COVAX, said Mike Muldoon, managing director for innovative finance at the Rockefeller Foundation.

Meanwhile, governments competed to secure contracts for vaccines by the hundreds of millions.

On Dec. 8, Britain became the first country to formally authorize a start to widespread vaccinations, injecting 90-year-old Margaret Keenan with a dose of the Pfizer-BioNTech vaccine. Six days later, the United States started its own vaccinations. And on Dec. 26, the EU followed suit. China and Russia had been vaccinating even before releasing data from their homegrown inoculations.

The Western companies with the most promising doses, including Pfizer/BioNTech, Moderna and AstraZeneca, had by then been churning out vials for months before formal approval, based on pledges from the wealthy countries that an enormous market awaited. Those doses were stockpiled in Europe and North America and a small number of countries, like Israel, that paid a premium.

COVAX pleaded for cash to do the same. Instead, it got pledges.

'As time passed and it became clear which vaccine candidates were going to be the leading contenders and which were most likely to succeed, the governments that had resources went and bought the supplies,' CEPI chief executive Dr. Richard Hatchett told the AP. 'COVAX was not in a position to do that.'